Wolverine Trading, LLC Coherus Bio Sciences, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.99 - $1.8 $7,326 - $13,320	-7,400 Reduced 39.36%	11,400 $11,000
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $3,160 - $5,020	2,000 Added 11.9%	18,800 $32,000
Q1 2024 May 15, 2024	SELL	$2.02 - $3.14 $31,310 - $48,670	-15,500 Reduced 47.99%	16,800 $40,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $12,243 - $29,645	-7,700 Reduced 19.25%	32,300 $107,000
Q3 2023 Nov 15, 2023	BUY	$3.74 - $5.45 $22,066 - $32,155	5,900 Added 17.3%	40,000 $149,000
Q2 2023 Aug 23, 2023	BUY	$3.79 - $8.3 $27,667 - $60,590	7,300 Added 27.24%	34,100 $145,000
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $58,311 - $104,148	9,900 Added 58.58%	26,800 $172,000
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $96,161 - $170,183	16,900 New	16,900 $134,000
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $139,776 - $210,048	-12,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $202,368 - $243,071	12,800 New	12,800 $214,000
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $131,872 - $185,016	-10,400 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$12.95 - $15.41 $134,680 - $160,264	10,400 New	10,400 $146,000
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $85,476 - $158,100	-10,200 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$8.65 - $16.28 $12,110 - $22,792	-1,400 Reduced 12.07%	10,200 $91,000
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $167,620 - $234,900	11,600 New	11,600 $191,000
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $117,390 - $176,730	-12,900 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$8.35 - $14.4 $15,865 - $27,360	-1,900 Reduced 12.84%	12,900 $114,000
Q3 2017 Nov 15, 2017	BUY	$11.1 - $14.5 $164,280 - $214,600	14,800	14,800 $198,000

Others Institutions Holding CHRS

# of Institutions

132

Shares Held

76.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$13.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$13.3 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$12.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$3.58 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$3.37 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account